Your session is about to expire
← Back to Search
BuMA Supreme Stent for Coronary Artery Disease
Study Summary
This trial is designed to compare the safety and efficacy of a new biodegradable stent to existing durable stents in patients with up to 3 coronary lesions. Up to 1632 subjects will be enrolled at 130 sites in North America, Japan, and Europe, and followed for up to 5 years.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am on or need long-term immunosuppressant therapy, but I can use corticosteroids.I am allergic to common heart medication metals, or contrast agents and can't be treated for it.I had a stent placed in my heart's artery within the last 3 months.I am scheduled for surgery that needs me to stop taking my blood thinning medication within 6 months.I am waiting for or have had an organ transplant.My kidney function is very low or I am on dialysis.I do not have a bleeding disorder and can take blood thinners.I am on or need long-term blood thinners.I am a man or a non-pregnant woman aged 20 or older.I am a suitable candidate for a specific heart procedure using stents and emergency heart bypass surgery.I had a major heart attack recently.I need a heart procedure due to my heart disease symptoms.My heart's pumping ability is very weak or I need a machine to help my heart pump blood.
- Group 1: BuMA Supreme Coronary Stent System
- Group 2: Xience or Promus Everolimus Stent System
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there still room for enrolment in this research trial?
"Clinicaltrials.gov discloses that this trial, originally posted on October 13th 2017, is no longer recruiting patients for participation. However, 573 other clinical trials are still open to enrollment as of February 12th 2021."
How many venues are hosting this experiment?
"This research is currently enrolling patients from 45 sites, including St. Michael's Hospital in Toronto, William Beaumont Hospital in Royal Oak, and Emory University Hospital in Atlanta."
Share this study with friends
Copy Link
Messenger